Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Snowflake shares rallied significantly following strong quarterly financial results that exceeded analyst expectations, bolstered by accelerated demand for the company's AI coding tools. While the community is divided between bullish sentiment regarding the company's AI-driven growth and skepticism over its high valuation and ongoing losses, intense trading volume has triggered a sharp upward move that has squeezed short positions.

Broadcom shares faced volatility following a fiscal fourth-quarter revenue outlook that fell slightly short of high-end estimates, despite the company reporting strong third-quarter results with massive growth in AI semiconductor revenue. Investors remain divided, with many bullish traders citing the company's long-term AI growth guidance—including targets for significant revenue expansion through 2028—as a signal to buy the dip, while others express caution regarding customer concentration and execution risks.

Credo Technology is experiencing significant downward pressure following its recent earnings report, despite beating estimates and raising guidance. Traders are debating whether the sell-off is an overreaction driven by concerns over margin compression, high customer concentration, and macro-economic factors, or if the stock is correcting from unsustainable valuation levels.

Ultragenyx is trending following the failure of its late-stage clinical trial for the experimental Angelman syndrome drug apazunersen (GTX-102), which missed its primary and secondary endpoints. While some traders are expressing concern over the pipeline setback and potential for further downside, others are pointing to the company's established commercial portfolio and upcoming catalysts as reasons to remain long or accumulate shares.

Oracle is trending due to the expansion of its AI partnership with HPE to scale global data center infrastructure, sparking debate about the company's valuation and cloud growth potential ahead of its upcoming earnings report. While some investors remain cautious due to debt concerns and technical volatility, many point to its massive cloud backlog and AI infrastructure demand as catalysts for a potential rebound.

Sarepta Therapeutics is experiencing significant buying pressure and volatility as investors look ahead to upcoming late-2026 clinical data readouts, specifically for its DM1 and FSHD programs. Traders are closely monitoring the company's recent leadership transition and the potential for a rebound in Elevidys revenue, while strong short interest continues to fuel speculation about a potential short squeeze or buyout.

Algorand is receiving attention as traders debate the project's long-term potential, focusing on its recent v5.0 mainnet upgrade, post-quantum cryptography features, and ongoing institutional adoption. While some participants are accumulating tokens in anticipation of a market-wide altcoin rally and the potential passage of the Clarity Act, others express significant skepticism, citing ongoing token dilution and poor historical price performance.

Dell Technologies is trending following a "blockbuster" earnings report that featured record revenue and a significant upward revision to its annual outlook, fueled by surging demand for AI-optimized servers. While the market responded with a wave of analyst price target hikes, retail sentiment remains sharply divided between bulls expecting further gains toward the $600 level and traders cautioning against volatility and perceived algorithmic manipulation.

Robinhood shares are trending as investors respond to bullish price target hikes from major analysts, citing the company's growth in prediction markets and its expanded business lines. While many traders are optimistic about the stock's momentum and the growth of the Robinhood Chain, there is notable disagreement, with some users expressing frustration over perceived price suppression and manipulation, while others remain bearish on the platform's long-term outlook.

C3.ai is trending following its fiscal fourth-quarter earnings report, which highlighted significant revenue declines and widened losses, leading to a polarized community reaction. While bears focus on the poor fundamentals and consistent cash burn, bulls are speculating on a potential short squeeze due to the stock's high short interest and confidence in the CEO's return and recent personal share purchase.